Vaccine Development

In the era of pandemics, lipid nanoparticles have emerged as critical components in mRNA vaccine formulations, exemplified by the success of COVID-19 vaccines. These nanoparticles facilitate efficient cellular uptake, ensuring the translation of viral antigens and prompting robust immune responses.

Articles

 

Advances in mRNA Technology

The success of COVID-19 mRNA vaccines has invigorated interest in leveraging mRNA for diverse clinical purposes. Early trials are investigating......

Read more >

 

Virus-like Particles

VLPs are nanoscale particles that look like viruses but are not infectious. They are composed of viral proteins that self-assemble into structures similar to a virus.....

Read more >

 

Coronavirus

In our societies where global travel has become the norm, the large scale transmission of infectious diseases is becoming of ever increasing concern.....

Read more >

 

Novel Spike Protein

A variant carrying a D614G mutation in the Spike (S) protein of SARS-CoV-2 emerged at an early stage of the...

Read more >

 

Covid-19 ELISA Assays

Novel Covid-19 IgG and IgM ELISA assays providing sensitive and reliable measurements of specific antibodies...

Read more >

 

Variant Spike Proteins

Isolated Spike Proteins from COVID-19 are available from Biorbyt, manufactured on a proprietary mammalian protein expression platform....

Read more >

 

Coronavirus Variants

At the beginning of 2003, the first severe coronavirus with pandemic potential emerged from China and spread to several other countries...

Read more >

 

Understanding Lipid Nanoparticles

Lipid nanoparticles represent a revolutionary class of drug delivery systems, designed to transport therapeutic payloads with precision and efficiency....

Read more >